Functional impact of tumor-specific N-linked glycan changes in breast and ovarian cancers

Advances in Cancer Research

Volumn 126, Issue , 2015, Pages 281-303

  Guo, Huabei ^a   Abbott, Karen L ^b  

^a UNIVERSITY OF GEORGIA   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Breast; Cancer; Functional impact; Glycan; N linked; Ovarian; Tumor

Indexed keywords

GLYCAN; GLYCOSYLTRANSFERASE; MANNOSE; N ACETYLGLUCOSAMINYLTRANSFERASE; POLYSACCHARIDE;

ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CELL DIFFERENTIATION; CELL PROLIFERATION; CONSENSUS SEQUENCE; ENZYME GLYCOSYLATION; FUCOSYLATION; FUT8 GENE; GENE; GENETIC CODE; GNT III GENE; GNT IV GENE; GNT V GENE; GOLGI COMPLEX; HETEROZYGOSITY LOSS; HUMAN; INTRACELLULAR SIGNALING; NONHUMAN; OVARY CANCER; PRIORITY JOURNAL; PROTEIN FOLDING; PROTEIN GLYCOSYLATION; PROTEIN STRUCTURE; QUALITY CONTROL; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT; BREAST TUMOR; CHEMISTRY; FEMALE; GLYCOBIOLOGY; GLYCOSYLATION; METABOLISM; OVARY TUMOR; PATHOLOGY; PROCEDURES;

BREAST NEOPLASMS; FEMALE; GLYCOMICS; GLYCOSYLATION; HUMANS; N-ACETYLGLUCOSAMINYLTRANSFERASES; OVARIAN NEOPLASMS; POLYSACCHARIDES;

EID: 84923295328     PISSN: 0065230X     EISSN: 21625557     Source Type: Book Series    
DOI: 10.1016/bs.acr.2014.11.006     Document Type: Chapter

References (92)

1. Abbott K.L., Aoki K., Lim J.M., Porterfield M., Johnson R., O'Regan R.M., et al. Targeted glycoproteomic identification of biomarkers for human breast carcinoma. Journal of Proteome Research 2008, 7(4):1470-1480. 10.1021/pr700792g.
2. Abbott K.L., Lim J.M., Wells L., Benigno B.B., McDonald J.F., Pierce M. Identification of candidate biomarkers with cancer-specific glycosylation in the tissue and serum of endometrioid ovarian cancer patients by glycoproteomic analysis. Proteomics 2010, 10(3):470-481. 10.1002/pmic.200900537.
3. Abbott K.L., Nairn A.V., Hall E.M., Horton M.B., McDonald J.F., Moremen K.W., et al. Focused glycomic analysis of the N-linked glycan biosynthetic pathway in ovarian cancer. Proteomics 2008, 8(16):3210-3220. 10.1002/pmic.200800157.
4. Abd Hamid U.M., Royle L., Saldova R., Radcliffe C.M., Harvey D.J., Storr S.J., et al. A strategy to reveal potential glycan markers from serum glycoproteins associated with breast cancer progression. Glycobiology 2008, 18(12):1105-1118. 10.1093/glycob/cwn095.
5. Aebi M. N-linked protein glycosylation in the ER. Biochimica et Biophysica Acta 2013, 1833(11):2430-2437. 10.1016/j.bbamcr.2013.04.001.
6. An H.J., Gip P., Kim J., Wu S., Park K.W., McVaugh C.T., et al. Extensive determination of glycan heterogeneity reveals an unusual abundance of high mannose glycans in enriched plasma membranes of human embryonic stem cells. Molecular and Cellular Proteomics 2012, 11(4). 10.1074/mcp.M111.010660.
7. Angata T., Varki A. Chemical diversity in the sialic acids and related alpha-keto acids: An evolutionary perspective. Chemical Reviews 2002, 102(2):439-469.
8. Anugraham M., Jacob F., Nixdorf S., Everest-Dass A.V., Heinzelmann-Schwarz V., Packer N.H. Specific glycosylation of membrane proteins in epithelial ovarian cancer cell lines: Glycan structures reflect gene expression and DNA methylation status. Molecular and Cellular Proteomics 2014, 13:2213-2232. 10.1074/mcp.M113.037085.
9. Bao X., Kobayashi M., Hatakeyama S., Angata K., Gullberg D., Nakayama J., et al. Tumor suppressor function of laminin-binding alpha-dystroglycan requires a distinct beta3-N-acetylglucosaminyltransferase. Proceedings of the National Academy of Sciences of the United States of America 2009, 106(29):12109-12114. 10.1073/pnas.0904515106.
10. Baselga J., Tripathy D., Mendelsohn J., Baughman S., Benz C.C., Dantis L., et al. Phase II study of weekly intravenous trastuzumab (Herceptin) in patients with HER2/neu-overexpressing metastatic breast cancer. Seminars in Oncology 1999, 26(4 (Suppl. 12)):78-83.
11. Beum P.V., Singh J., Burdick M., Hollingsworth M.A., Cheng P.W. Expression of core 2 beta-1,6-N-acetylglucosaminyltransferase in a human pancreatic cancer cell line results in altered expression of MUC1 tumor-associated epitopes. The Journal of Biological Chemistry 1999, 274(35):24641-24648.
12. Buckhaults P., Chen L., Fregien N., Pierce M. Transcriptional regulation of N-acetylglucosaminyltransferase V by the src oncogene. The Journal of Biological Chemistry 1997, 272(31):19575-19581.
13. Burchell J., Wang D., Taylor-Papadimitriou J. Detection of the tumour-associated antigens recognized by the monoclonal antibodies HMFG-1 and 2 in serum from patients with breast cancer. International Journal of Cancer 1984, 34(6):763-768.
14. Cazet A., Julien S., Bobowski M., Burchell J., Delannoy P. Tumour-associated carbohydrate antigens in breast cancer. Breast Cancer Research 2010, 12(3):204. 10.1186/bcr2577.
15. Chen L., Zhang W., Fregien N., Pierce M. The her-2/neu oncogene stimulates the transcription of N-acetylglucosaminyltransferase V and expression of its cell surface oligosaccharide products. Oncogene 1998, 17(16):2087-2093. 10.1038/sj.onc.1202124.
16. Choi H.J., Chung T.W., Kim C.H., Jeong H.S., Joo M., Youn B., et al. Estrogen induced beta-1,4-galactosyltransferase 1 expression regulates proliferation of human breast cancer MCF-7 cells. Biochemical and Biophysical Research Communications 2012, 426(4):620-625. 10.1016/j.bbrc.2012.08.140.
17. Christiansen M.N., Chik J., Lee L., Anugraham M., Abrahams J.L., Packer N.H. Cell surface protein glycosylation in cancer. Proteomics 2014, 14(4-5):525-546. 10.1002/pmic.201300387.
18. Christie D.R., Shaikh F.M., Lucas J.A.t., Lucas J.A., Bellis S.L. ST6Gal-I expression in ovarian cancer cells promotes an invasive phenotype by altering integrin glycosylation and function. Journal of Ovarian Research 2008, 1(1):3. 10.1186/1757-2215-1-3.
19. Cohen M., Varki A. The sialome-Far more than the sum of its parts. Omics 2010, 14(4):455-464. 10.1089/omi.2009.0148.
20. de Leoz M.L., Young L.J., An H.J., Kronewitter S.R., Kim J., Miyamoto S., et al. High-mannose glycans are elevated during breast cancer progression. Molecular and Cellular Proteomics 2011, 10(1). M110.002717. 10.1074/mcp.M110.002717.
21. Debnath J., Muthuswamy S.K., Brugge J.S. Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. Methods 2003, 30(3):256-268.
22. Dennis J.W., Brewer C.F. Density-dependent lectin-glycan interactions as a paradigm for conditional regulation by posttranslational modifications. Molecular and Cellular Proteomics 2013, 12(4):913-920. 10.1074/mcp.R112.026989.
23. Dube V.E., Kallio P., Chmiel J.S., Haid M., Hakim A. An immunosorbent assay for blood group I antigens in breast carcinoma. Clinical Immunology and Immunopathology 1987, 45(2):196-207.
24. Federici M.F., Kudryashov V., Saigo P.E., Finstad C.L., Lloyd K.O. Selection of carbohydrate antigens in human epithelial ovarian cancers as targets for immunotherapy: Serous and mucinous tumors exhibit distinctive patterns of expression. International Journal of Cancer 1999, 81(2):193-198.
25. Fernandes B., Sagman U., Auger M., Demetrio M., Dennis J.W. Beta 1-6 branched oligosaccharides as a marker of tumor progression in human breast and colon neoplasia. Cancer Research 1991, 51(2):718-723.
26. Fukuda M., Hiraoka N., Yeh J.C. C-type lectins and sialyl Lewis X oligosaccharides. Versatile roles in cell-cell interaction. The Journal of Cell Biology 1999, 147(3):467-470.
27. Garcia-Bunuel R., Monis B. Histochemical observations on mucins in human ovarian neoplasms. Cancer 1964, 17:1108-1118.
28. Gerken T.A., Jamison O., Perrine C.L., Collette J.C., Moinova H., Ravi L., et al. Emerging paradigms for the initiation of mucin-type protein O-glycosylation by the polypeptide GalNAc transferase family of glycosyltransferases. The Journal of Biological Chemistry 2011, 286(16):14493-14507. 10.1074/jbc.M111.218701.
29. Granovsky M., Fata J., Pawling J., Muller W.J., Khokha R., Dennis J.W. Suppression of tumor growth and metastasis in Mgat5-deficient mice. Nature Medicine 2000, 6(3):306-312. 10.1038/73163.
30. Guo H.B., Johnson H., Randolph M., Lee I., Pierce M. Knockdown of GnT-Va expression inhibits ligand-induced downregulation of the epidermal growth factor receptor and intracellular signaling by inhibiting receptor endocytosis. Glycobiology 2009, 19(5):547-559. 10.1093/glycob/cwp023.
31. Guo H.B., Johnson H., Randolph M., Nagy T., Blalock R., Pierce M. Specific posttranslational modification regulates early events in mammary carcinoma formation. Proceedings of the National Academy of Sciences of the United States of America 2010, 107(49):21116-21121. 10.1073/pnas.1013405107.
32. Guo H., Nairn A., dela Rosa M., Nagy T., Zhao S., Moremen K., et al. Transcriptional regulation of the protocadherin beta cluster during Her-2 protein-induced mammary tumorigenesis results from altered N-glycan branching. The Journal of Biological Chemistry 2012, 287(30):24941-24954. 10.1074/jbc.M112.369355.
33. Guo H.B., Randolph M., Pierce M. Inhibition of a specific N-glycosylation activity results in attenuation of breast carcinoma cell invasiveness-related phenotypes: Inhibition of epidermal growth factor-induced dephosphorylation of focal adhesion kinase. The Journal of Biological Chemistry 2007, 282(30):22150-22162. 10.1074/jbc.M611518200.
34. Hakomori S. Glycosylation defining cancer malignancy: New wine in an old bottle. Proceedings of the National Academy of Sciences of the United States of America 2002, 99(16):10231-10233. 10.1073/pnas.172380699.
35. Hakomori S., Wang S.M., Young W.W. Isoantigenic expression of Forssman glycolipid in human gastric and colonic mucosa: Its possible identity with "a-like antigen" in human cancer. Proceedings of the National Academy of Sciences of the United States of America 1977, 74(7):3023-3027.
36. Handerson T., Camp R., Harigopal M., Rimm D., Pawelek J. Beta1,6-branched oligosaccharides are increased in lymph node metastases and predict poor outcome in breast carcinoma. Clinical Cancer Research 2005, 11(8):2969-2973. 10.1158/1078-0432.CCR-04-2211.
37. Hao Y.Y., Lin B., Zhao Y., Zhang Y.H., Li F.F., Diao B., et al. Alpha1,2-fucosyltransferase gene transfection influences on biological behavior of ovarian carcinoma-derived RMG-I cells. Fen Zi Xi Bao Sheng Wu Xue Bao 2008, 41(6):435-442.
38. Hellstrom I., Garrigues H.J., Garrigues U., Hellstrom K.E. Highly tumor-reactive, internalizing, mouse monoclonal antibodies to Le(y)-related cell surface antigens. Cancer Research 1990, 50(7):2183-2190.
39. Hirano K., Matsuda A., Shirai T., Furukawa K. Expression of LacdiNAc groups on N-glycans among human tumors is complex. BioMed Research International 2014, 2014:981627. 10.1155/2014/981627.
40. Hudak J.E., Canham S.M., Bertozzi C.R. Glycocalyx engineering reveals a Siglec-based mechanism for NK cell immunoevasion. Nature Chemical Biology 2014, 10(1):69-75. 10.1038/nchembio.1388.
41. Iida A., Kurose K., Isobe R., Akiyama F., Sakamoto G., Yoshimoto M., et al. Mapping of a new target region of allelic loss to a 2-cM interval at 22q13.1 in primary breast cancer. Genes, Chromosomes & Cancer 1998, 21(2):108-112.
42. Isshiki S., Togayachi A., Kudo T., Nishihara S., Watanabe M., Kubota T., et al. Cloning, expression, and characterization of a novel UDP-galactose: beta-N-acetylglucosamine beta1,3-galactosyltransferase (beta3Gal-T5) responsible for synthesis of type 1 chain in colorectal and pancreatic epithelia and tumor cells derived therefrom. The Journal of Biological Chemistry 1999, 274(18):12499-12507.
43. Julien S., Ivetic A., Grigoriadis A., QiZe D., Burford B., Sproviero D., et al. Selectin ligand sialyl-Lewis x antigen drives metastasis of hormone-dependent breast cancers. Cancer Research 2011, 71(24):7683-7693. 10.1158/0008-5472.CAN-11-1139.
44. Kelleher D.J., Gilmore R. An evolving view of the eukaryotic oligosaccharyl transferase. Glycobiology 2006, 16(4):47R-62R. 10.1093/glycob/cwj066.
45. Kitamura N., Guo S., Sato T., Hiraizumi S., Taka J., Ikekita M., et al. Prognostic significance of reduced expression of beta-N-acetylgalactosaminylated N-linked oligosaccharides in human breast cancer. International Journal of Cancer 2003, 105(4):533-541. 10.1002/ijc.11115.
46. Ko J.H., Miyoshi E., Noda K., Ekuni A., Kang R., Ikeda Y., et al. Regulation of the GnT-V promoter by transcription factor Ets-1 in various cancer cell lines. The Journal of Biological Chemistry 1999, 274(33):22941-22948.
47. Kurimoto A., Kitazume S., Kizuka Y., Nakajima K., Oka R., Fujinawa R., et al. The absence of core fucose up-regulates GnT-III and Wnt target genes: A possible mechanism for an adaptive response in terms of glycan function. The Journal of Biological Chemistry 2014, 289(17):11704-11714. 10.1074/jbc.M113.502542.
48. Kyselova Z., Mechref Y., Kang P., Goetz J.A., Dobrolecki L.E., Sledge G.W., et al. Breast cancer diagnosis and prognosis through quantitative measurements of serum glycan profiles. Clinical Chemistry 2008, 54(7):1166-1175. 10.1373/clinchem.2007.087148.
49. Lakshminarayanan V., Thompson P., Wolfert M.A., Buskas T., Bradley J.M., Pathangey L.B., et al. Immune recognition of tumor-associated mucin MUC1 is achieved by a fully synthetic aberrantly glycosylated MUC1 tripartite vaccine. Proceedings of the National Academy of Sciences of the United States of America 2012, 109(1):261-266. 10.1073/pnas.1115166109.
50. Li D., Li Y., Wu X., Li Q., Yu J., Gen J., et al. Knockdown of Mgat5 inhibits breast cancer cell growth with activation of CD4+ T cells and macrophages. The Journal of Immunology 2008, 180(5):3158-3165.
51. Li F.F., Liu J.J., Liu D.W., Lin B., Hao Y.Y., Cong J.P., et al. Lewis Y regulates signaling molecules of the transforming growth factor beta pathway in ovarian carcinoma-derived RMG-I cells. International Journal of Oncology 2012, 40(4):1196-1202. 10.3892/ijo.2011.1296.
52. Lin S., Kemmner W., Grigull S., Schlag P.M. Cell surface alpha 2,6 sialylation affects adhesion of breast carcinoma cells. Experimental Cell Research 2002, 276(1):101-110. 10.1006/excr.2002.5521.
53. Liu J., Lin B., Hao Y., Qi Y., Zhu L., Li F., et al. Lewis y antigen promotes the proliferation of ovarian carcinoma-derived RMG-I cells through the PI3K/Akt signaling pathway. Journal of Experimental & Clinical Cancer Research 2009, 28:154. 10.1186/1756-9966-28-154.
54. Machado E., Kandzia S., Carilho R., Altevogt P., Conradt H.S., Costa J. N-Glycosylation of total cellular glycoproteins from the human ovarian carcinoma SKOV3 cell line and of recombinantly expressed human erythropoietin. Glycobiology 2011, 21(3):376-386. 10.1093/glycob/cwq170.
55. Madjd Z., Parsons T., Watson N.F., Spendlove I., Ellis I., Durrant L.G. High expression of Lewis y/b antigens is associated with decreased survival in lymph node negative breast carcinomas. Breast Cancer Research 2005, 7(5):R780-R787. 10.1186/bcr1305.
56. Miyoshi E., Noda K., Yamaguchi Y., Inoue S., Ikeda Y., Wang W., et al. The alpha1-6-fucosyltransferase gene and its biological significance. Biochimica et Biophysica Acta 1999, 1473(1):9-20.
57. Moremen K.W., Tiemeyer M., Nairn A.V. Vertebrate protein glycosylation: Diversity, synthesis and function. Nature Reviews. Molecular Cell Biology 2012, 13(7):448-462. 10.1038/nrm3383.
58. Muthuswamy S.K., Li D., Lelievre S., Bissell M.J., Brugge J.S. ErbB2, but not ErbB1, reinitiates proliferation and induces luminal repopulation in epithelial acini. Nature Cell Biology 2001, 3(9):785-792. 10.1038/ncb0901-785.
59. Nagahata T., Hirano A., Utada Y., Tsuchiya S., Takahashi K., Tada T., et al. Correlation of allelic losses and clinicopathological factors in 504 primary breast cancers. Breast Cancer 2002, 9(3):208-215.
60. Nairn A.V., Aoki K., dela Rosa M., Porterfield M., Lim J.M., Kulik M., et al. Regulation of glycan structures in murine embryonic stem cells: Combined transcript profiling of glycan-related genes and glycan structural analysis. The Journal of Biological Chemistry 2012, 287(45):37835-37856. 10.1074/jbc.M112.405233.
61. Nairn A.V., York W.S., Harris K., Hall E.M., Pierce J.M., Moremen K.W. Regulation of glycan structures in animal tissues: Transcript profiling of glycan-related genes. The Journal of Biological Chemistry 2008, 283(25):17298-17313. 10.1074/jbc.M801964200.
62. Nakagoe T., Fukushima K., Itoyanagi N., Ikuta Y., Oka T., Nagayasu T., et al. Expression of ABH/Lewis-related antigens as prognostic factors in patients with breast cancer. Journal of Cancer Research and Clinical Oncology 2002, 128(5):257-264. 10.1007/s00432-002-0334-5.
63. Nakamori S., Kameyama M., Imaoka S., Furukawa H., Ishikawa O., Sasaki Y., et al. Increased expression of sialyl Lewisx antigen correlates with poor survival in patients with colorectal carcinoma: Clinicopathological and immunohistochemical study. Cancer Research 1993, 53(15):3632-3637.
64. Narasimhan S. Control of glycoprotein synthesis. UDP-GlcNAc:glycopeptide beta 4-N-acetylglucosaminyltransferase III, an enzyme in hen oviduct which adds GlcNAc in beta 1-4 linkage to the beta-linked mannose of the trimannosyl core of N-glycosyl oligosaccharides. The Journal of Biological Chemistry 1982, 257(17):10235-10242.
65. Partridge E.A., Le Roy C., Di Guglielmo G.M., Pawling J., Cheung P., Granovsky M., et al. Regulation of cytokine receptors by Golgi N-glycan processing and endocytosis. Science 2004, 306(5693):120-124. 10.1126/science.1102109.
66. Potapenko I.O., Haakensen V.D., Luders T., Helland A., Bukholm I., Sorlie T., et al. Glycan gene expression signatures in normal and malignant breast tissue; possible role in diagnosis and progression. Molecular Oncology 2010, 4(2):98-118. 10.1016/j.molonc.2009.12.001.
67. Rabinovich G.A., van Kooyk Y., Cobb B.A. Glycobiology of immune responses. The Annals of the New York Academy of Sciences 2012, 1253:1-15. 10.1111/j.1749-6632.2012.06492.x.
68. Saldova R., Piccard H., Perez-Garay M., Harvey D.J., Struwe W.B., Galligan M.C., et al. Increase in sialylation and branching in the mouse serum N-glycome correlates with inflammation and ovarian tumour progression. PLoS One 2013, 8(8):e71159. 10.1371/journal.pone.0071159.
69. Saldova R., Royle L., Radcliffe C.M., Abd Hamid U.M., Evans R., Arnold J.N., et al. Ovarian cancer is associated with changes in glycosylation in both acute-phase proteins and IgG. Glycobiology 2007, 17(12):1344-1356. 10.1093/glycob/cwm100.
70. Saldova R., Struwe W.B., Wynne K., Elia G., Duffy M.J., Rudd P.M. Exploring the glycosylation of serum CA125. International Journal of Molecular Sciences 2013, 14(8):15636-15654. 10.3390/ijms140815636.
71. Saldova R., Wormald M.R., Dwek R.A., Rudd P.M. Glycosylation changes on serum glycoproteins in ovarian cancer may contribute to disease pathogenesis. Disease Markers 2008, 25(4-5):219-232.
72. Schachter H. Biosynthetic controls that determine the branching and microheterogeneity of protein-bound oligosaccharides. Biochemistry and Cell Biology 1986, 64(3):163-181.
73. Schwientek T., Nomoto M., Levery S.B., Merkx G., van Kessel A.G., Bennett E.P., et al. Control of O-glycan branch formation. Molecular cloning of human cDNA encoding a novel beta1,6-N-acetylglucosaminyltransferase forming core 2 and core 4. The Journal of Biological Chemistry 1999, 274(8):4504-4512.
74. Shimodaira K., Nakayama J., Nakamura N., Hasebe O., Katsuyama T., Fukuda M. Carcinoma-associated expression of core 2 beta-1,6-N-acetylglucosaminyltransferase gene in human colorectal cancer: Role of O-glycans in tumor progression. Cancer Research 1997, 57(23):5201-5206.
75. Siddiqui S.F., Pawelek J., Handerson T., Lin C.Y., Dickson R.B., Rimm D.L., et al. Coexpression of beta1,6-N-acetylglucosaminyltransferase V glycoprotein substrates defines aggressive breast cancers with poor outcome. Cancer Epidemiology, Biomarkers and Prevention 2005, 14(11 Pt. 1):2517-2523. 10.1158/1055-9965.EPI-05-0464.
76. Siegel R., Ma J., Zou Z., Jemal A. Cancer statistics, 2014. CA: A Cancer Journal for Clinicians 2014, 64(1):9-29. 10.3322/caac.21208.
77. Song Y., Aglipay J.A., Bernstein J.D., Goswami S., Stanley P. The bisecting GlcNAc on N-glycans inhibits growth factor signaling and retards mammary tumor progression. Cancer Research 2010, 70(8):3361-3371. 10.1158/0008-5472.CAN-09-2719.
78. Steentoft C., Vakhrushev S.Y., Joshi H.J., Kong Y., Vester-Christensen M.B., Schjoldager K.T., et al. Precision mapping of the human O-GalNAc glycoproteome through SimpleCell technology. The EMBO Journal 2013, 32(10):1478-1488. 10.1038/emboj.2013.79.
79. Stiles G.L., Benovic J.L., Caron M.G., Lefkowitz R.J. Mammalian beta-adrenergic receptors. Distinct glycoprotein populations containing high mannose or complex type carbohydrate chains. The Journal of Biological Chemistry 1984, 259(13):8655-8663.
80. Takahashi T., Ikeda Y., Miyoshi E., Yaginuma Y., Ishikawa M., Taniguchi N. Alpha1,6fucosyltransferase is highly and specifically expressed in human ovarian serous adenocarcinomas. International Journal of Cancer 2000, 88(6):914-919.
81. Tsuji S. Molecular cloning and functional analysis of sialyltransferases. Journal of Biochemistry 1996, 120(1):1-13.
82. Ugorski M., Laskowska A. Sialyl Lewis(a): A tumor-associated carbohydrate antigen involved in adhesion and metastatic potential of cancer cells. Acta Biochimica Polonica 2002, 49(2):303-311.
83. Ujita M., McAuliffe J., Suzuki M., Hindsgaul O., Clausen H., Fukuda M.N., et al. Regulation of I-branched poly-N-acetyllactosamine synthesis. Concerted actions by I-extension enzyme, I-branching enzyme, and beta1,4-galactosyltransferase I. The Journal of Biological Chemistry 1999, 274(14):9296-9304.
84. Uozumi N., Yanagidani S., Miyoshi E., Ihara Y., Sakuma T., Gao C.X., et al. Purification and cDNA cloning of porcine brain GDP-L-Fuc:N-acetyl-beta-D-glucosaminide alpha1-6fucosyltransferase. The Journal of Biological Chemistry 1996, 271(44):27810-27817.
85. Varki A., Freeze H.H. The major glycosylation pathways of mammalian membranes. A summary. Subcellular Biochemistry 1994, 22:71-100.
86. Varki A., Kannagi R., Toole B.P. Glycosylation changes in cancer. Essentials of glycobiology 2009, Cold Spring Harbor, New York. 2nd ed. A. Varki, R.D. Cummings, J.D. Esko, H.H. Freeze, P. Stanley, C.R. Bertozzi (Eds.).
87. Varki N.M., Varki A. Diversity in cell surface sialic acid presentations: Implications for biology and disease. Laboratory Investigation 2007, 87(9):851-857. 10.1038/labinvest.3700656.
88. Wang X., Gu J., Miyoshi E., Honke K., Taniguchi N. Phenotype changes of Fut8 knockout mouse: Core fucosylation is crucial for the function of growth factor receptor(s). Methods in Enzymology 2006, 417:11-22. 10.1016/S0076-6879(06)17002-0.
89. Wang X., Inoue S., Gu J., Miyoshi E., Noda K., Li W., et al. Dysregulation of TGF-beta1 receptor activation leads to abnormal lung development and emphysema-like phenotype in core fucose-deficient mice. Proceedings of the National Academy of Sciences of the United States of America 2005, 102(44):15791-15796. 10.1073/pnas.0507375102.
90. Yamaguchi H., Uchida M. A chaperone-like function of intramolecular high-mannose chains in the oxidative refolding of bovine pancreatic RNase B. Journal of Biochemistry 1996, 120(3):474-477.
91. Yang X., Liu S., Yan Q. Role of fucosyltransferase IV in epithelial-mesenchymal transition in breast cancer cells. Cell Death and Disease 2013, 4:e735. 10.1038/cddis.2013.241.
92. Zhang H., Meng F., Wu S., Kreike B., Sethi S., Chen W., et al. Engagement of I-branching {beta}-1, 6-N-acetylglucosaminyltransferase 2 in breast cancer metastasis and TGF-{beta} signaling. Cancer Research 2011, 71(14):4846-4856. 10.1158/0008-5472.CAN-11-0414.